Rapid Cellular Phenotyping of Human Pluripotent Stem Cell-Derived Cardiomyocytes using a Genetically Encoded Fluorescent Voltage Sensor  by Leyton-Mange, Jordan S. et al.
Stem Cell Reports
ReportRapid Cellular Phenotyping of Human Pluripotent Stem Cell-Derived
Cardiomyocytes using a Genetically Encoded Fluorescent Voltage Sensor
Jordan S. Leyton-Mange,1 Robert W. Mills,1 Vincenzo S. Macri,1 Min Young Jang,1 Faraz N. Butte,1
Patrick T. Ellinor,1 and David J. Milan1,*
1Cardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA 02129, USA
*Correspondence: dmilan@partners.org
http://dx.doi.org/10.1016/j.stemcr.2014.01.003
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which
permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.SUMMARYIn addition to their promise in regenerativemedicine, pluripotent stem cells have proved to be faithful models of many human diseases.
In particular, patient-specific stem cell-derived cardiomyocytes recapitulate key features of several life-threatening cardiac arrhythmia
syndromes. For both modeling and regenerative approaches, phenotyping of stem cell-derived tissues is critical. Cellular phenotyping
has largely relied upon expression of lineage markers rather than physiologic attributes. This is especially true for cardiomyocytes, in
part because electrophysiological recordings are labor intensive. Likewise, most optical voltage indicators suffer from phototoxicity,
which damages cells and degrades signal quality. Here we present the use of a genetically encoded fluorescent voltage indicator, ArcLight,
whichwe demonstrate can faithfully report transmembrane potentials in human stem cell-derived cardiomyocytes.We demonstrate the
application of this fluorescent sensor in high-throughput, serial phenotyping of differentiating cardiomyocyte populations and in
screening for drug-induced cardiotoxicity.INTRODUCTION
Amajor advance in disease modeling has been the demon-
stration that human induced pluripotent stem cell tech-
nology can faithfully recapitulate many human diseases,
including cardiac arrhythmia syndromes (Kim et al.,
2013; Matsa et al., 2011; Roden and Hong, 2013). For
cardiac diseases, there is interest in applying these models
to large-scale screens for novel therapeutics or drug toxic-
ities; however, efforts have been frustrated by the labor-
intensive nature of conventional electrophysiological
recordings (Mercola et al., 2013). Optical mapping with
voltage indicators is an alternative, yet voltage-sensitive
dyes, such as ANEPPS dyes, have inherent phototoxicity
that limits the recording time and can degrade signal qual-
ity (Herron et al., 2012).
The field of genetically encoded voltage probes is rapidly
evolving. Arch(D95N) (Kralj et al., 2012) is photostable and
highly voltage sensitive, but in absolute terms is 100–1,000
times dimmer than GFP, necessitating the use of advanced
imaging techniques. More recently, a novel voltage indica-
tor, ArcLight, was developed by fusing the voltage-sensing
domain of the Ciona intestinalis voltage-sensitive phospha-
tase to a super ecliptic pHluorin carrying the point muta-
tion A227D (Cao et al., 2013; Jin et al., 2012).
Although ArcLight probes have limited frequency re-
sponses, they still may be suitable for monitoring cardiac
action potentials (APs). Here, we demonstrate the use of
A242-ArcLight (ArcLight) to noninvasively report APs
from human embryonic stem cell-derived cardiomyocytesStem Cell(hESC-CMs). We demonstrate the utility of ArcLight for
characterizing hESC-CMs by reporting AP durations
(APDs) over a broad range. In addition, ArcLight allows
accurate recognition of early afterdepolarizations (EADs),
as well as CM subtypes. Comparison with simultaneous
patch-clamp recordings reveals consistent but relatively
small errors due to the temporal response of this protein
voltage reporter.
RESULTS
Fluorescence Measurement of APs in hESC-CMs
ArcLight expression in H7 hESC-CMs resulted in robust
optical signals (Figure 1A) that were visible to the naked
eye even in single isolated cells (Movie S1 available online).
AP morphology, a functional marker of CM subtype, was
readily recognized, permitting identification of atrial,
nodal, and ventricular AP morphologies (Figure 1B). Fluo-
rescent signals were remarkably photostable, permitting
prolonged recording over minutes of continuous illumi-
nation (Figures S1A and S1B). In contrast, recordings
from di-8-ANEPPS-loaded hESC-CMs displayed phototox-
icity after several gated 6 s recordings (Figure S1C).
Compared with patch-clamp electrophysiology, fluores-
cence data were rapidly acquired and APs from multiple
cells in a single field could be simultaneously recorded
(Figure 1C), permitting recordings from over 440 single
hESC-CMs and small groups (<5 cells) in 1 day. This
throughput allowed characterization of large cell popula-
tions by APD and morphology (Figures S1D–S1F).Reports j Vol. 2 j 163–170 j February 11, 2014 j ª2014 The Authors 163
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Figure 1. Rapid and Simultaneous
Recording of APs in hESC-CMs
(A) Representative ArcLight fluorescence
tracing from a single isolated hESC-CM with
three images corresponding to (i) phase 4,
(ii) plateau phase 2, and (iii) phase 4.
Trace bar equals 200 ms. Scale bar, 50 mm
(image).
(B) Representative fluorescence traces de-
picting typical atrial, nodal, and ventricular
AP morphologies. Scale bar, 1 s.
(C) Still-frame image of several single
ArcLight expressing hESC-CMs and corre-
sponding simultaneous fluorescence traces.
Scale bars, 100 mm (image) and 2 s (trace).
(D) Differentiating clusters of ArcLight-
expressing hESC-CMs on day 19 with
selected fluorescence recordings. Scale
bars, 400 mm (image) and 500 ms (trace).
See also Figure S1.
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Rapid hESC-CM Electrophysiological PhenotypingIn addition to direct lentiviral transduction of differen-
tiated CMs, we also introduced the ArcLight construct
at the ESC stage, with a mean proviral integration of
7.5 copies/cell. Under a CAG promoter, ArcLight expres-
sion rose upon cardiac differentiation within the trans-
duced population as well as in subsequently derived clonal
lines, and persisted through months of culture (Orba´n
et al., 2009). This enabled serial monitoring of composite
APs during CM differentiation while preserving the integ-
rity and sterility of the cell culture (Figure 1D; Movie S2).164 Stem Cell Reports j Vol. 2 j 163–170 j February 11, 2014 j ª2014 The AAccuracy in Reporting Transmembrane Potentials
We compared ArcLight fluorescence with simultaneous
patch-clamp recordings in hESC-CMs (Figure 2A). The
morphological characteristics of cardiac APs were well
resolved, albeit with some loss of high-frequency compo-
nents. Fluorescentmeasurements of APD90 showed a linear
correlation with simultaneous current-clamp values with a
consistent overestimation of 62 ms over a broad range of
APDs (R2 = 0.86; Figure 2B). Likewise, optical measure-
ments of APD90 also correlated closely to AP voltage-clamputhors
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Figure 2. Accuracy of ArcLight Reporting
of Transmembrane Potential Changes
(A) Unfiltered fluorescence recording (red)
overlaid on a simultaneous current-clamp
recording (black) during a spontaneous AP
in an hESC-CM. Scale bars, 20 mV and
100 ms.
(B) Fluorescence measurement of APD90
plotted against APD90 measured by simul-
taneous current-clamp recordings with the
best-fit line shown in black. The red line
represents unity.
(C) Fluorescence (red) from an ArcLight-
expressing hESC-CM and concurrent
voltage-clamp protocol (black).
(D) Fluorescence-voltage relationship
derived from five cells using the clamp
protocol in (C). Data are mean ± SEM. Linear
regression is shown for potentials from
60 mV to 20 mV.
(E) Fitted biexponential time constants
(red) overlaid on a representative fluores-
cence response to a voltage step of 90 mV
to 60 mV in an ArcLight-expressing hESC-
CM. Scale bar, 500 ms.
See also Figure S2.
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Rapid hESC-CM Electrophysiological Phenotypingcommands corresponding to human ventricular APDs
cycling at frequencies from 1 to 6 Hz (R2 = 0.99; Figure S2A;
Lou et al., 2012). Voltage-clamp step commands were used
to record fluorescence response over a range of voltages
(Figure 2C). While the fluorescence voltage relationship
was sigmoidal (R2 = 0.994; Figures S2B and S2C), a linear
approximation was operative from –60 mV to 20 mV,
with an 18.52% change per 100 mV (R2 = 0.991, reference
90 mV; Figure 2D). Spanning this range of potentials, the
fluorescent signal/noise ratio was 22.35 ± 2.74 dB. Consis-
tent with prior reports (Jin et al., 2012), the temporal
response was biexponential (Figure 2E), with tdepol,1 =
15.64 ± 1.33ms and tdepol,2 = 86.15 ± 12.32ms, and relative
amplitudes Adepol,1:Adepol,2 = 1.06 ± 0.17. The repolariza-Stem Celltion constants were trepol,1 = 15.78 ± 1.82 ms and trepol,2 =
112.71 ± 18.59 ms, with relative amplitudes Arepol,1:
Arepol,2 = 4.93 ± 0.77. To assess whether ArcLight expression
affects the electrophysiological properties of the cells, we
compared APDs measured using current-clamp recordings
from wild-type cells with fluorescent recordings from
ArcLight-transduced cells. No significant differences were
observed, although this experiment was limited by the
inherent cellular heterogeneity of hESC-CMs (Figure S2C;
p = 0.9).
Serial Imaging of Differentiating CMs
A major obstacle to stem cell disease modeling and regen-
erative applications is the difficulty of obtaining matureReports j Vol. 2 j 163–170 j February 11, 2014 j ª2014 The Authors 165
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Figure 3. Serial Phenotyping of Differentiating CM Populations
(A) Fluorescence traces from differentiating hESC-CM clusters on
days 25 and 40, treated and untreated with 1 mmol/L ATRA during
days 5–8 (untreated: day 25, n = 106, day 40, n = 86; retinoic acid:
day 25, n = 26, day 40, n = 30).
(B and C) APD90 (B) and APD20/APD90 (C) measurements from
fluorescence waveforms in untreated and ATRA-treated hESC-CM
clusters on day 40.
See also Figure S3.
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phenotyping during ongoing cellular differentiation
might provide valuable information for overcoming this
barrier. During cardiac differentiation, some ArcLight-
transduced hESCs were treated with all-trans retinoic
acid (ATRA) on days 5–8 of differentiation, which has
been reported to promote an atrial phenotype (Zhang
et al., 2011). On day 25 and again on day 40, >100 CM
clusters were imaged. On day 25, ATRA-treated CMs dis-
played shorter APD90 compared with untreated cells
(416 ± 147 ms versus 509 ± 120 ms, p < 0.001; Figure S3A).
AP plateaus, measured as APD20/APD90, were also
decreased in ATRA-treated hESC-CMs relative to untreated
cells (0.41 ± 0.09 versus 0.54 ± 0.10, 24% reduction, p <166 Stem Cell Reports j Vol. 2 j 163–170 j February 11, 2014 j ª2014 The A0.001; Figure S3B). At day 40, these differences were
more pronounced (Figures 3B and 3C), with shorter
mean APD90 in ATRA-treated cells versus controls (152 ±
59 ms versus 268 ± 70 ms, p < 0.001) and a smaller
mean APD20/APD90 ratio (0.44 ± 0.08 versus 0.66 ±
0.08, p < 0.001). In order to assess the susceptibility of
these recordings to motion artifact, we used cell clusters,
which are more prone to motion artifacts than individual
cells. A comparison of recordings before and after treat-
ment with 20 mM blebbistatin revealed no statistically
significant change in APD90 measurements, suggesting
that the effects of motion artifact are limited in this
setting (p = 0.918; Figure S3C).
Rapid Evaluation of Drug-Induced Repolarization
Toxicity
We then tested the ability of the ArcLight fluorescent
transmembrane voltage reporter to resolve electrophysio-
logical changes after application of dofetilide, a blocker
of the rapid component of the delayed rectifier current
(IKr). Dofetilide prolongs the cardiac AP and can be
proarrhythmic at high doses (Roden, 2004). Compared
with simultaneous current-clamp recordings, fluorescence
recordings from ArcLight-transduced cells faithfully re-
ported AP prolongation and EADs (Figure 4A). Dofetilide
treatment of hESC-CM clusters increased the mean
APD90 (449 ± 170 ms versus 268 ± 70 ms, p < 0.001,
n = 85; Figure 4B). Paired recordings showed that
dofetilide mediated increases in APD90 (Figure 4C). Dofe-
tilide effects were greatest at cycle lengths greater than
700 ms (Figure 4D), consistent with the recognized
reverse use dependence of IKr blockers (Roden, 2004). In
addition to APD prolongation, optical recordings reported
APD shortening in hESC-CMs field paced at 1.5 Hz
following application of pinacidil (Figure S4A), an opener
of the ATP-sensitive K+ current (IK,ATP), which was pre-
viously reported to shorten APD in human induced
pluripotent stem cell-derived CMs (Itzhaki et al., 2011).
Consistent with prior work (Tang et al., 2012), pinacidil-
mediated shortening was more pronounced during early
repolarization, with APD20, APD50, APD80, and APD90
decreasing by 25.2% ± 16.8%, 23.3% ± 14.3%, 15.4% ±
12.2%, and 9.6% ± 10.1%, respectively (p % 0.001 for
all, n = 18; Figure S4B). We also investigated the capacity
of ArcLight fluorescence to resolve changes in upstroke
velocity by applying 3 mmol/L tetrodotoxin (TTX), a
dose that was previously demonstrated to prolong the
diastolic interval and decrease dV/dtmax by 50% in
hESC-CMs (Satin et al., 2004). Predictably, based on the
temporal response of the reporter (Figure 2E), d(F)/dtmax
was unaltered after TTX treatment, although we did
observe prolongation of the diastolic interval (Figures
S4C–S4E; p = 0.83).uthors
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Figure 4. Rapid Evaluation of Drug-
Induced Repolarization Toxicity
(A) Current-clamp (black) and simultaneous
fluorescence tracing (red) from an ArcLight-
expressing hESC-CM before and after exposure
to 20 nmol/L dofetilide. EADs and APD pro-
longation are seen in both recordings. Scale
bars, 20 mV and 1 s.
(B) APD90 and cycle length measurements
from fluorescent tracings of hESC-CM clusters
before and after 20 nmol/L dofetilide (n = 86
before and after).
(C) Paired APD90 measurement from nine
hESC-CM clusters before and after 20 nmol/L
dofetilide.
(D) Analysis by cycle length of APD90 esti-
mates in (B). Error bars represent SEM. *p =
0.03, **p = 0.002, ***p < 0.001.
See also Figure S4.
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We have demonstrated a method to obtain fluorescent
recordings of transmembrane potential changes in hESC-
CMs with an approximately linear relationship over a
broad range of potentials. Recent years have seen dramatic
improvements in stem cell culture methods (Chen et al.,
2011; Schinzel et al., 2011); however, similar impro-
vements in phenotyping have not always followed. The
optical measurements described here provide much higher
throughput than traditional techniques and should
streamline cellular phenotyping.
There is ongoing interest in identifying methods to
encourage CM maturation (Kim et al., 2013; Lieu et al.,
2013). The ArcLight fluorescent reporter allows noninva-
sive and nondestructive phenotyping of an entire hESC-Stem CellCM population over multiple time points. In our example,
treatment with ATRA during days 5–8 resulted in relatively
minor differences at day 25, but by day 40 the differences
were much more robust, emphasizing the value of serial
recordings.
One of the most common causes of postmarket drug
withdrawal has been drug-induced QT prolongation and
torsade de pointes, which remains difficult to predict in
the preclinical setting (Roden, 2004). Although there is
enthusiasm for hESC-CM models of cardiotoxicity (Roden
andHong, 2013), cellular heterogeneity and the challenges
of high-throughput cellular electrophysiology have limited
their widespread application. The fluorescent method
described here is amenable to high-throughput screening,
and the ability to perform serial measurements could
permit each cell to serve as its own control.Reports j Vol. 2 j 163–170 j February 11, 2014 j ª2014 The Authors 167
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rescence signals report relative, not absolute, membrane
potentials. The temporal response results in loss of high-
frequency elements and leads to a small but systematic
overestimation of APD. A comparison of ArcLight and
the ANEPPS dyes (Herron et al., 2012) reveals certain
trade-offs. Although genetic manipulation may not always
be practical, once it is genetically introduced, ArcLight
requires no further cellular manipulation, which may pro-
vide advantages for delicate cellular preparations. Another
difference is the lower phototoxicity of ArcLight compared
with di-4-ANEPPS and di-8-ANEPPS, which enables longer-
duration and serial recordings. The signal/noise ratios
measured in this work are comparable to those measured
with the newer voltage-sensitive dye di-4-ANBDQBS in
ventricularmyocytes, using a similarmethod of calculation
(Warren et al., 2010). A final difference is the frequency
response of these two probes: the ANEPPS dyes have a clear
advantage for applications that require a fast temporal
response. It should be noted that in this study, we could
not rule out the possibility that ArcLight expression had
small effects on the electrophysiology of the cells.
In conclusion, phenotyping of hESC-CMs with ArcLight
provides a robust means to noninvasively characterize
and quantify changes in cellular electrophysiology. This
facile tool will find use in studies that require rapid charac-
terization of cell populations, such as efforts to understand
the cues for CM differentiation, as well as in screening for
cardiotoxicity and novel therapeutics.EXPERIMENTAL PROCEDURES
Molecular Biology
A242-ArcLight cDNA (Addgene plasmid 36857) was used for tran-
sient transfection (Jin et al., 2012). cDNA was PCR amplified
with the following primers:
Forward: 50-GGGGACAAGTTTGTACAAAAAAGCAGGCTACCATGGAG
GGATTCGACGGTTCAG-30
Reverse: 50-GGGGACCACTTTGTACAAGAAAGCTGGGTTCATTTGTAT
AGTTCATCCATGCCATG-30
The resulting product was recombined into pDONR221 with BP
Clonase (Invitrogen) and sequence verified. A cassette flanked by
attR sites and encoding the ccdB and chloramphenicol resistance
genes (Invitrogen) was cloned into the SmaI site of the lentiviral
expression vector pLV-EF1a-MCS-IRES-mCherry-Neo (Biosettia).
The EF1a promoter was then excised with BspDI and XbaI diges-
tion, and replaced by the CAG promoter from psPAX2 (Addgene
plasmid 12260) (Zufferey et al., 1997) following digestion with
SalI and EcoRI, and ligation of the following adapters:
50 adaptor: 50- CGATCCCGGGCTCGAGG-30 annealed to 50-Pi-TCGACC
TCGAGCCCGGGAT-30
30 adaptor: 50-Pi-AATTCTTCGAAGCGATCGCG-30 annealed to 50-CTA
GCGCGATCGCTTCGAAG-30168 Stem Cell Reports j Vol. 2 j 163–170 j February 11, 2014 j ª2014 The AA242-ArcLight within pDONR221 was recombined with LR
Clonase (Invitrogen) into the resulting destination vector to create
pLV-CAG-ArcLight. A CMV-driven lentiviral construct was created
by recombining A242-ArcLight into pLenti-CMV-Puro-DEST to
create pLenti-CMV-ArcLight (Addgene plasmid 17452) (Campeau
et al., 2009).
hESC Culture and CM Differentiation
The H7 hESC line (WA07; WiCell) was maintained in feeder-free
culture in Essential 8 medium (Chen et al., 2011) on Geltrex extra-
cellular matrix (Invitrogen). Differentiation to the CM lineage was
performed by combining an extracellular matrix sandwich using
an overlay of a 1:100 dilution of Geltrex at the onset of differenti-
ation (day 0), analogous to techniques previously reported (Zhang
et al., 2012), along with temporal modulation of canonical Wnt
signaling as previously described (Lian et al., 2012). When indi-
cated, 1 mmol/L ATRA (Sigma) was supplemented between days 5
and 8. CMs between days 30 and 90 were dissociated by mechan-
ically isolating contracting cell clusters and exposing them to three
to six successive 5–7 min treatments with 0.25% Trypsin-EDTA
(GIBCO). Dissociated cells were collected between treatments,
centrifuged, resuspended in Dulbecco’s modified Eagle’s medium
with 20% fetal bovine serum (GIBCO), and plated onto Geltrex-
coated glass coverslips. RPMI 1640 medium with B27 supplement
(Invitrogen) was overlaid 24 hr later and replaced approximately
every 3 days. Cells were permitted to recover for 48 hr prior to
further manipulation.
Transient Transfection of hESC-CMs
Lipofectamine LTX (Invitrogen)was used for transient transfection
of dissociatedhESC-CMs.Cells were imaged 24–48 hr posttransfec-
tion. The data represented in Figure 4A were acquired in pilot ex-
periments by transient transfection. Because it provided decreased
toxicity, better efficiency of gene transfer, and stable expression
levels, lentiviral transductionwas favored for all subsequent exper-
iments and is represented in all other data shown.
Lentiviral Production and Transduction
Lentiviral vectors were packaged in human embryonic kidney
293 (HEK293) cells by cotransfection using Lipofectamine LTX
with psPAX2 (Addgene plasmid 12260) (Zufferey et al., 1997)
and pCMV-VSV-G (Addgene plasmid 8454) (Stewart et al., 2003).
Lentivirus-containing supernatants were harvested at 48 and
72 hr posttransfection, passaged through 0.45 mmfilters (Nalgene),
and concentrated using PEG-it (System Biosciences). Dissociated
H7 hESC-CMs were transduced with pLenti-CMV-ArcLight lenti-
virus for 48–72 hr and imaged 3–5 days after the onset of transduc-
tion (data in Figures 1A–1C and all of Figures 2, S1, S2, and S4). H7
hESCs were transduced with pLV-CAG-ArcLight lentivirus for 16 hr
in the presence of 6 mg/ml polybrene (Sigma). After 72 hr, the
medium was supplemented with 300 mg/ml G418 (GIBCO) to
select an expressing population (data from subsequently derived
hESC-CM clusters are represented in Figures 1D and 4B–4D, and
all of Figures 3 and S3). Clonal lines were derived by further enrich-
ing for ArcLight-expressing cells by fluorescence-activated cell
sorting with a fluorescein isothiocyanate (FITC) filter. Cells were
plated at low density (200 cells/cm2) and cultured in the presenceuthors
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Those exhibiting homogeneous FITC fluorescence were expanded
further. Proviral integration copy number was measured by quan-
titative PCRwith the Lenti-X Provirus Quantitation kit (Clontech).
Fluorescence Microscopy
Cells were imaged in a bath chamber or culture dish at 37C in a
bath solution identical to that used for electrophysiology record-
ings, with a Nikon Eclipse Ti-U inverted microscope, a Nikon CFI
S Fluor 103 objective (NA 0.5, WD 1.2 mm), and a NeuroCCDSM
camera (RedShirtImaging). An FITC filter set (excitation: HQ480,
mirror: Q505LP, emission: HQ535/50 m; Chroma) was used
for ArcLight fluorescence measurements, and a customized set
(excitation: Omega Optical 525QM45, mirror: Chroma 565 dcxr,
emission: Chroma HQ635LP) was used for di-8-ANEPPS. An X-
Cite exacte mercury arc lamp (Lumen Dynamics) was used for
illumination and typically set at 70%–100% output. Images were
recorded at 500 or 1,000 frames per second. Movie S2 was recorded
with an ORCA-Flash2.8 camera (Hamamatsu). Where indicated,
20 mmol/L blebbistatin was applied to hESC-CM clusters for
30 min. Di-8-ANEPPS was loaded at 5 mmol/l for 20 min at 37C
andwashedwith bath solution prior to immediate imaging (Hardy
et al., 2006). For drug experiments with dissociated hESC-CMs,
bath solutions containing TTX, dofetilide, or pinacidil (all Sigma)
were perfused into the bath chamber prior to imaging and electro-
physiological recordings. For the cell-cluster experiments depicted
in Figures 4B–4D, dofetilide was added to the culture medium for
30 min and exchanged for bath solution containing dofetilide
just prior to imaging. Where stated, AP firing frequency was
controlled by field pacing using an RC-49MFSHperfusion chamber
(Warner Instruments) and S48 Stimulator (Grass Products).
Electrophysiology
Electrophysiological recordings were performed with a ruptured
patchwhole-cell configuration at 37C (TC-344Bheater controller;
Warner Instruments). The bath solution contained (mmol/L) 140
NaCl, 5.4 KCl, 1.8 CaCl2, 1 MgCl2, 10 HEPES, 10 glucose, pH 7.4
with NaOH, and the pipette solution contained 120 K-aspartate,
20 KCl, 1.8 CaCl2, 5 Mg-ATP, 5 NaCl, 10 HEPES, 5 EGTA, pH 7.3
with KOH (all Sigma). Fire-polished patch electrodes had 2–5 MU
resistance. Recordings were low-pass filtered at 5 kHz with an
Axopatch 200B amplifier and digitized at 10 kHz with a Digidata
1440A A/D converter, both controlled with Clampex software
(Axon Instruments). Voltage-clamp step recordings were per-
formed with a clamp at 90 mV followed by 1 s depolarizing
steps to 60, 40, 20, 0, 20, 40, 60, and 80 mV, with 1 s recov-
eries at 90 mV between steps. AP voltage-clamp commands were
designed based on previously measured human ventricular APDs
at various cycle lengths (Lou et al., 2012).
Data Processing
NeuroPlex software (RedShirtImaging) was used to view image se-
quences and output darkfield-corrected mean fluorescence from
regions of interest. Optical recordings were inverted and low-pass
filtered at 100 Hz or, where stated, reported as unfiltered traces.
Fluorophore photobleaching was subtracted using a custom pro-
gram. DF/F90 from voltage step commands was calculated byStem Celldividing the mean steady-state fluorescence responses by the
mean fluorescence at 90 mV. Double exponentials of probe
dynamics were fit using Clampfit software (Axon Instruments).
The signal/noise ratio was calculated by dividing the difference
in mean steady-state fluorescence values recorded at 60 mV and
20 mV by the root-mean-square of the mean-subtracted steady-
state fluorescence signal. APDX was calculated to be the time
interval between when signals reached 50% of the difference in
fluorescence between the initiation and maximal height of an up-
stroke, and x% of the return to diastolic baseline. d(F)/dtmax was
computed as the maximal instantaneous change in fluorescence
normalized to the difference in fluorescence between the initiation
and maximal height of the upstroke. Statistical comparisons of
d(F)/dtmax and APD90 patch versus APD90 optical were made by
using Student’s two-tailed t test. Those of APDX before and after
pinacidil were made using a paired two-tailed t test. All other
statistical comparisons of APD90 and APD20/APD90 were made
using the Mann-Whitney rank sum test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and two movies
and can be found with this article online at http://dx.doi.org/10.
1016/j.stemcr.2014.01.003.
ACKNOWLEDGMENTS
This work was supported by the Corrigan Minehan Foundation
(D.J.M.), the Harvard Stem Cell Institute (D.J.M.), the NIH
(grants R01HL109004 to D.J.M.; R01HL092577, R01HL104156,
and 1K24HL105780 to P.T.E.; and T32HL007208 to J.L.M. and
R.W.M.), the American Heart Association (grant 13EIA14220013
to P.T.E.), and the Heart Rhythm Society (V.S.M.).
Received: October 18, 2013
Revised: January 2, 2014
Accepted: January 7, 2014
Published: February 6, 2014REFERENCES
Campeau, E., Ruhl, V.E., Rodier, F., Smith, C.L., Rahmberg, B.L.,
Fuss, J.O., Campisi, J., Yaswen, P., Cooper, P.K., and Kaufman,
P.D. (2009). A versatile viral system for expression and depletion
of proteins in mammalian cells. PLoS ONE 4, e6529.
Cao, G., Platisa, J., Pieribone, V.A., Raccuglia, D., Kunst, M., and
Nitabach, M.N. (2013). Genetically targeted optical electrophysi-
ology in intact neural circuits. Cell 154, 904–913.
Chen, G., Gulbranson, D.R., Hou, Z., Bolin, J.M., Ruotti, V., Pro-
basco, M.D., Smuga-Otto, K., Howden, S.E., Diol, N.R., Propson,
N.E., et al. (2011). Chemically defined conditions for human
iPSC derivation and culture. Nat. Methods 8, 424–429.
Hardy, M.E., Lawrence, C.L., Standen, N.B., and Rodrigo, G.C.
(2006). Can optical recordings of membrane potential be used to
screen for drug-induced action potential prolongation in single
cardiac myocytes? J. Pharmacol. Toxicol. Methods 54, 173–182.
Herron, T.J., Lee, P., and Jalife, J. (2012). Optical imaging of voltage
and calcium in cardiac cells & tissues. Circ. Res. 110, 609–623.Reports j Vol. 2 j 163–170 j February 11, 2014 j ª2014 The Authors 169
Stem Cell Reports
Rapid hESC-CM Electrophysiological PhenotypingItzhaki, I., Maizels, L., Huber, I., Zwi-Dantsis, L., Caspi, O., Winter-
stern, A., Feldman, O., Gepstein, A., Arbel, G., Hammerman, H.,
et al. (2011). Modelling the long QT syndrome with induced
pluripotent stem cells. Nature 471, 225–229.
Jin, L., Han, Z., Platisa, J., Wooltorton, J.R., Cohen, L.B., and
Pieribone, V.A. (2012). Single action potentials and subthreshold
electrical events imaged in neurons with a fluorescent protein
voltage probe. Neuron 75, 779–785.
Kim, C., Wong, J., Wen, J., Wang, S., Wang, C., Spiering, S., Kan,
N.G., Forcales, S., Puri, P.L., Leone, T.C., et al. (2013). Studying
arrhythmogenic right ventricular dysplasia with patient-specific
iPSCs. Nature 494, 105–110.
Kralj, J.M., Douglass, A.D., Hochbaum, D.R., Maclaurin, D., and
Cohen, A.E. (2012). Optical recording of action potentials in
mammalian neurons using a microbial rhodopsin. Nat. Methods
9, 90–95.
Lian, X., Hsiao, C., Wilson, G., Zhu, K., Hazeltine, L.B., Azarin,
S.M., Raval, K.K., Zhang, J., Kamp, T.J., and Palecek, S.P. (2012).
Robust cardiomyocyte differentiation from human pluripotent
stem cells via temporal modulation of canonical Wnt signaling.
Proc. Natl. Acad. Sci. USA 109, E1848–E1857.
Lieu, D.K., Fu, J.D., Chiamvimonvat, N., Tung, K.C., McNerney,
G.P., Huser, T., Keller, G., Kong, C.W., and Li, R.A. (2013).
Mechanism-based facilitated maturation of human pluripotent
stem cell-derived cardiomyocytes. Circ. Arrhythm. Electrophysiol.
6, 191–201.
Lou, Q., Janks, D.L., Holzem, K.M., Lang, D., Onal, B., Ambrosi,
C.M., Fedorov, V.V., Wang, I.W., and Efimov, I.R. (2012). Right
ventricular arrhythmogenesis in failing human heart: the role of
conduction and repolarization remodeling. Am. J. Physiol. Heart
Circ. Physiol. 303, H1426–H1434.
Matsa, E., Rajamohan, D., Dick, E., Young, L., Mellor, I., Staniforth,
A., and Denning, C. (2011). Drug evaluation in cardiomyocytes
derived from human induced pluripotent stem cells carrying a
long QT syndrome type 2 mutation. Eur. Heart J. 32, 952–962.
Mercola, M., Colas, A., and Willems, E. (2013). Induced pluripo-
tent stem cells in cardiovascular drug discovery. Circ. Res. 112,
534–548.
Orba´n, T.I., Apa´ti, A., Ne´meth, A., Varga, N., Krizsik, V., Scham-
berger, A., Szebe´nyi, K., Erdei, Z., Va´rady, G., Kara´szi, E., et al.
(2009). Applying a ‘‘double-feature’’ promoter to identify
cardiomyocytes differentiated from human embryonic stem cells170 Stem Cell Reports j Vol. 2 j 163–170 j February 11, 2014 j ª2014 The Afollowing transposon-based gene delivery. Stem Cells 27, 1077–
1087.
Roden, D.M. (2004). Drug-induced prolongation of the QT
interval. N. Engl. J. Med. 350, 1013–1022.
Roden, D.M., andHong, C.C. (2013). Stem cell-derived cardiomyo-
cytes as a tool for studying proarrhythmia: a better canary in the
coal mine? Circulation 127, 1641–1643.
Satin, J., Kehat, I., Caspi, O., Huber, I., Arbel, G., Itzhaki, I., Magyar,
J., Schroder, E.A., Perlman, I., and Gepstein, L. (2004). Mechanism
of spontaneous excitability in human embryonic stem cell derived
cardiomyocytes. J. Physiol. 559, 479–496.
Schinzel, R.T., Ahfeldt, T., Lau, F.H., Lee, Y.K., Cowley, A., Shen, T.,
Peters, D., Lum, D.H., and Cowan, C.A. (2011). Efficient culturing
and genetic manipulation of human pluripotent stem cells. PLoS
ONE 6, e27495.
Stewart, S.A., Dykxhoorn, D.M., Palliser, D., Mizuno, H., Yu, E.Y.,
An, D.S., Sabatini, D.M., Chen, I.S., Hahn, W.C., Sharp, P.A.,
et al. (2003). Lentivirus-delivered stable gene silencing by RNAi
in primary cells. RNA 9, 493–501.
Tang, L., Joung, B., Ogawa, M., Chen, P.S., and Lin, S.F. (2012).
Intracellular calcium dynamics, shortened action potential
duration, and late-phase 3 early afterdepolarization in Langen-
dorff-perfused rabbit ventricles. J. Cardiovasc. Electrophysiol. 23,
1364–1371.
Warren, M., Spitzer, K.W., Steadman, B.W., Rees, T.D., Venable, P.,
Taylor, T., Shibayama, J., Yan, P.,Wuskell, J.P., Loew, L.M., and Zait-
sev, A.V. (2010). High-precision recording of the action potential
in isolated cardiomyocytes using the near-infrared fluorescent
dye di-4-ANBDQBS. Am. J. Physiol. Heart Circ. Physiol. 299,
H1271–H1281.
Zhang, Q., Jiang, J., Han, P., Yuan, Q., Zhang, J., Zhang, X., Xu, Y.,
Cao, H., Meng, Q., Chen, L., et al. (2011). Direct differentiation of
atrial and ventricular myocytes from human embryonic stem cells
by alternating retinoid signals. Cell Res. 21, 579–587.
Zhang, J., Klos, M., Wilson, G.F., Herman, A.M., Lian, X., Raval,
K.K., Barron,M.R., Hou, L., Soerens, A.G., Yu, J., et al. (2012). Extra-
cellular matrix promotes highly efficient cardiac differentiation of
human pluripotent stem cells: the matrix sandwich method. Circ.
Res. 111, 1125–1136.
Zufferey, R., Nagy, D., Mandel, R.J., Naldini, L., and Trono, D.
(1997). Multiply attenuated lentiviral vector achieves efficient
gene delivery in vivo. Nat. Biotechnol. 15, 871–875.uthors
